Patient experiences regarding ASCUS or low grade SIL cervicovaginal cytology results in two institutions in Bogotá (Colombia), 2014
DOI:
https://doi.org/10.18597/rcog.3Keywords:
Cytology, qualitative research, emotional responseAbstract
Objective: To describe patient knowledge regarding the use of cytology, as well as the emotions and behaviours elicited by a positive vaginal cytology result of atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LG-SIL).
Materials and methods: Qualitative phenomenological research aimed at identifying experiences among women between 18 and 69 years of age presenting for the first time because of a cervicovaginal cytology finding of ASCUS or LG-SIL to the cervical pathology units of two intermediate complexity centres in Bogota, one of them a public institution and the other a private outpatient centre. The sample size was determined by theoretical saturation on the basis of a consecutive sampling. Focus groups and interviews were conducted, and the information was recorded and transcribed afterwards. Categories were created for experience assessment: socio-demographic and affective characteristics, cognition, and behaviour. Editing was used for a narrative analysis style in order to organize the information gathered for synthesis and interpretation purposes.
Results: Twenty-seven women were included. An abnormal cytology result gives rise to feelings of guilt and is associated with anxiety and fear of
having cervical cancer, given that it is not clear to them that cervicovaginal cytology is a screening test. The main behaviour after receiving the cytology result was to give priority to the medical appointment. There are changes in the relationships with the partners due to perceived infidelity secondary to HPV infection.
Conclusions: Cervicovaginal cytology is is considered by patients of the greatest importance and mandatory given the need to prevent and treat
cervical cancer.
Author Biographies
Solange Monsalve-Páez
Diana Valderrama-Vega
Marcos Fidel Castillo-Zamora
Yahira Rossini Guzmán-Sabogal
Jairo Amaya-Guío
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Cancer Incidence and Mortality Worldwide: IARC. Globocan. 2012; v1.0.
Instituto Nacional de Cancerología. Guía de Práctica Clínica. Recomendaciones para el tratamiento de las pacientes con citología reportada con células escamosas atípicas de significado indeterminado (ASC-US) en Colombia; 2007. [Visitado: 2014 Feb14]. Disponible en: http://www.nacer.udea.edu.co/pdf/jornadas/2ascus2.pdf
Stewart Massad L, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. Update Consensus Guidelines for the management of Abnormal Cervical Cancer Screening Test and Cancer Precursors. American Society for Colposcopy and Cer vical Pathology Journal of Lower Genital Tract Disease. 2013;17:S1-S27.
Monsonego J, Cortes J, da Silva DP, Jorge AF, Klein P. Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. BMC Womens Health. 2011;11:18.
Herzog T, Wright J. The impact of cervical cancer on quality of life–the components and means for management. Gynecol Oncol. 2007;107:572-7.
Petticrew MP, Sowden AJ, Lister-Sharp D, Wright K. False-negative result in screening programmes: systematic review of impact and implications. Health Technol Assess. 2000;4:1-120.
Bonelli L, Branca M, Ferreri M, Barizzone D, Rossi E, Cedri S, et al. Attitude of women towards early cancer detection and estimation of the compliance to a screening program for cervix and breast cancer. Cancer Detect Prev. 1996;20:342-52.
Hellsten C, Sjöström K, Lindqvist PG. A longitudinal 2-year follow-up of quality of life in women refer for colposcopy after an abnormal cervical smear. Eur J Obstet Gynecol Reprod Biol. 2009;147:221-5.
Campbell H, MacDonald S, McKiernan M. Promotion of cervical screening uptake by health visitor follow-up of women who repeatedly failed. J Public Health Med. 1996;18:94-7.
Escobar J. Grupos Focales una guía conceptual y metodológica. Cuadernos Hispanoamericanos de Psicología. 2010;9:57-6.
Larios FE, Robles R, Jiménez LM, Suárez AE, del Toro A, Danieri A. Información y soporte emocional a las mujeres con resultado anormal en Papanicolaou: una guía de comunicación. Psicooncología. 2009;6:155-66.
Zeisler H, Mayerhofer K, Joura EA, Sator M, Kainz C. Psychological burden of women with mild cervical intraepithelial neoplasia. Oncol Rep. 1997;4:1063-5.
Simon MA, Cofta-Woerpel L, Randhawa V, John P, Makoul G, Spring B. Using the word ‘cancer’ in communication about an abnormal Pap test: finding common ground with patient-provider communication. Patient Educ Couns. 2010;81:106-12.
Peiró G, Corbellas C, Camps C, Sánchez PT, Peiró G, Godes M, et al. Estudio descriptivo sobre el proceso de comunicar el diagnóstico y el pronóstico en oncología. Psicooncología. 2006;3:9-17.
Fylan F. Screening for cervical cancer: a review of women’s attitudes, knowledge, and behaviour. Br J Gen Pract. 1998;48;1509-14.
Maissi E, Marteau ET, Hankins M, Moss S, Legood R, Gray A. Psychological impact of human papilloma virus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study. BMJ. 2004;328:1293.
McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006;82:169-74.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
